286 related articles for article (PubMed ID: 17702867)
21. Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine.
Schank JR; Ventura R; Puglisi-Allegra S; Alcaro A; Cole CD; Liles LC; Seeman P; Weinshenker D
Neuropsychopharmacology; 2006 Oct; 31(10):2221-30. PubMed ID: 16395294
[TBL] [Abstract][Full Text] [Related]
22. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y
Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490
[TBL] [Abstract][Full Text] [Related]
23. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
[TBL] [Abstract][Full Text] [Related]
24. Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.
Hansard MJ; Smith LA; Jackson MJ; Cheetham SC; Jenner P
J Pharmacol Exp Ther; 2002 Dec; 303(3):952-8. PubMed ID: 12438514
[TBL] [Abstract][Full Text] [Related]
25. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
26. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
Nishi K; Kondo T; Narabayashi H
No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
[TBL] [Abstract][Full Text] [Related]
27. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
[TBL] [Abstract][Full Text] [Related]
28. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
29. 7-Fluoro-1,3-diphenylisoquinoline reverses motor and non-motor symptoms induced by MPTP in mice: Role of striatal neuroinflammation.
Sampaio TB; Marcondes Sari MH; Pesarico AP; Mantovani AC; Zeni G; Nogueira CW
Eur J Pharmacol; 2018 Jan; 819():129-135. PubMed ID: 29217173
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
[TBL] [Abstract][Full Text] [Related]
31. A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets.
Iravani MM; Syed E; Jackson MJ; Johnston LC; Smith LA; Jenner P
Eur J Neurosci; 2005 Feb; 21(4):841-54. PubMed ID: 15787691
[TBL] [Abstract][Full Text] [Related]
32. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
33. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
[TBL] [Abstract][Full Text] [Related]
34. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
35. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
[TBL] [Abstract][Full Text] [Related]
36. Acoustic startle response, prepulse inhibition, and spontaneous locomotor activity in MPTP-treated mice.
Leng A; Yee BK; Feldon J; Ferger B
Behav Brain Res; 2004 Oct; 154(2):449-56. PubMed ID: 15313033
[TBL] [Abstract][Full Text] [Related]
37. Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults.
Gupta M; Gupta BK; Thomas R; Bruemmer V; Sladek JR; Felten DL
Neurosci Lett; 1986 Oct; 70(3):326-31. PubMed ID: 3490639
[TBL] [Abstract][Full Text] [Related]
38. Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward.
Olson VG; Heusner CL; Bland RJ; During MJ; Weinshenker D; Palmiter RD
Science; 2006 Feb; 311(5763):1017-20. PubMed ID: 16484499
[TBL] [Abstract][Full Text] [Related]
39. Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice.
Lv Y; Zhang Z; Hou L; Zhang L; Zhang J; Wang Y; Liu C; Xu P; Liu L; Gai X; Lu T
Neurosci Lett; 2015 Jun; 597():132-6. PubMed ID: 25929185
[TBL] [Abstract][Full Text] [Related]
40. Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease.
Kim SN; Doo AR; Park JY; Bae H; Chae Y; Shim I; Lee H; Moon W; Lee H; Park HJ
PLoS One; 2011; 6(11):e27566. PubMed ID: 22132113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
